PharmaRoth Labs (PharmaRoth Labs) Total Stockholders Equity : $-0.30 Mil (As of Mar. 2011)

View and export this data going back to 2008. Start your Free Trial

What is PharmaRoth Labs Total Stockholders Equity?

PharmaRoth Labs's Total Stockholders Equity for the quarter that ended in Mar. 2011 was $-0.30 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. PharmaRoth Labs's Book Value per Share for the quarter that ended in Mar. 2011 was $-0.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. PharmaRoth Labs's Debt-to-Equity for the quarter that ended in Mar. 2011 was 0.00.

PharmaRoth Labs Total Stockholders Equity Historical Data

The historical data trend for PharmaRoth Labs's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaRoth Labs Total Stockholders Equity Chart

PharmaRoth Labs Annual Data

Trend

Jun08

Jun09

Jun10

Total Stockholders Equity

-0.01

-0.02

-0.29

PharmaRoth Labs Quarterly Data
	Mar07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
Total Stockholders Equity	Get a 7-Day Free Trial											-0.04	-0.29	-0.31	-0.32	-0.30

PharmaRoth Labs (GREY:ROTH) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

PharmaRoth Labs's Book Value per Share for the quarter that ended in Mar. 2011 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-0.295	-	0)	/	149.35
	=	-0.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

PharmaRoth Labs's Debt-to-Equity for the quarter that ended in Mar. 2011 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	-0.295
	=	0.00

PharmaRoth Labs Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of PharmaRoth Labs's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaRoth Labs (PharmaRoth Labs) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaRoth Labs Inc (GREY:ROTH) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

8250 West Charleston Boulevard, Suite 110, Las Vegas, NV, USA, 89117

Website

http://www.pharmaroth.com

PharmaRoth Labs Inc is engaged in the manufacture and sale of a treatment for Type II diabetes called Sucanon. The company also does marketing and selling of nutraceutical drugs.

PharmaRoth Labs (PharmaRoth Labs) Headlines

From GuruFocus

Hotchkis and Wiley Value Opportunities Fund Buys Rothschild SCA, Oracle Corp, Medtronic PLC, Sells Amerco Inc, Anthem Inc, F5 Inc

By GuruFocusNews insider • 03-29-2022